He said that hedge fund ownership of potential deregulation beneficiaries, stocks with small business exposure, and domestic ...
Goldman Sachs has appointed insiders William Connolly and Michael Voris as co-heads of Equity Capital Markets (ECM) in the ...
Goldman Sachs analyst Matt Greene maintained a Buy rating on Glencore (GLEN – Research Report) today and set a price target of £5.00. The ...
Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
4d
Hosted on MSNASX Broker Moves: Upgrades for A2 Milk Co., Cochlear, Pro Medicus vs Downgrades for Westpac, James Hardie IndustriesGraincorp (GNC), Judo Capital (JDO), Northern Star Resources (NST), Pro Medicus (PME), Treasury Wine (TWE). Downgrades: AGL ...
In a report released on February 14, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price ...
Investors, shrugging off ongoing concerns around trade and inflation, are searching for the next catalyst to send stocks ...
These three premier ASX healthcare stocks just reported half-yearly earnings – and each saw its share price dip…So, is now the time to buy?
Investors seeking to outperform the market should focus their stock-picking efforts on volatile names in the consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results